SCHEMBL28802438

SCHEMBL28802438

Cc1ccc(C(=O)ON=O)c(Cl)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.43
POLB P06746 1/20 0.38
MAPT P10636 4/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 6/20 0.35
RAB9A P51151 6/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
PARP1 P09874 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PKM P14618 2/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ACLY P53396 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27924300 0.83 RAB9A (0.35) POLBMAPTKMT2ANPC1RAB9A
SCHEMBL29453741 0.81 EGFR (0.50) EGFRMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL334079 0.81 EGFR (0.50) EGFRMAPTNPC1RAB9ASMN1; SMN2
Nitrous Acid SCHEMBL28033243 0.79 PARP1 (0.47) EGFRPOLBKMT2ASMN1; SMN2ALDH1A1
SCHEMBL3583155 0.78 TSHR (0.52) EGFRMAPTKMT2AHPGDALDH1A1
Nitrous Acid SCHEMBL27969683 0.77 EGFR (0.50) EGFRKMT2ASMN1; SMN2HPGDALDH1A1
SCHEMBL5190356 0.77 POLB (0.52) EGFRPOLBKMT2ASMN1; SMN2ALDH1A1
SCHEMBL23345398 0.77 EGFR (0.43) EGFRPOLBMAPTKMT2ASMN1; SMN2
SCHEMBL27564870 0.77 NPC1 (0.43) POLBMAPTKMT2ANPC1RAB9A
SCHEMBL27644815 0.76 TUBB4A (0.40) NPC1RAB9AALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102858742-A Trpv1 vanilloid receptor antagonists with a bicyclic portion PHARMESTE SRL 2013-01-02 CN disclosed